Some genetic alterations, such as those occurring at the level of PI3KCA, MAP3K1, CDH1, and GATA3 genes are more frequent among ER+ than ER- breast cancers; in contrast, TP53 alterations are markedly more frequent in ER- than ER+ breast cancers [49]. This evidence concerns the gene CDH1 and breast cancer.